Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCH-III: Treatment Protocol for Langerhans Cell Histiocytosis
NCT00276757Phase 3Completed
- Sponsor
- Histiocyte Society
- Start
- Apr 2001
- Modality
- Orthosteric Ligands
- Countries
- 10
01
Overview
A Phase 3 trial of methotrexate in Langerhans cell histiocytosis (LCH), sponsored by Histiocyte Society. Started Apr 2001; status: completed.
02
Drugs
methotrexate
03
Conditions
Langerhans cell histiocytosis (LCH)
Beyond the preview
Go deeper on NCT00276757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276757.